Megan Huizenga

2014- Pharmacology  Georgetown University, Washington, DC 
"Megan Huizenga"
Mean distance: 15.09 (cluster 19)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Culjat M, Huizenga MN, Forcelli PA. (2020) Age-dependent anticonvulsant actions of perampanel and brivaracetam in the methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM) model of seizures in developing rats. Pharmacological Reports : Pr
Huizenga MN, Sepulveda-Rodriguez A, Forcelli PA. (2019) Preclinical safety and efficacy of cannabidivarin for early life seizures. Neuropharmacology. 148: 189-198
Huizenga MN, Forcelli PA. (2018) Neuroprotective Action of the CB1/2 Receptor Agonist, WIN 55,212-2, against DMSO but Not Phenobarbital-Induced Neurotoxicity in Immature Rats. Neurotoxicity Research
Huizenga MN, Fureman BE, Soltesz I, et al. (2018) Proceedings of the Epilepsy Foundation's 2017 Cannabinoids in Epilepsy Therapy Workshop. Epilepsy & Behavior : E&B
Queenan BN, Dunn RL, Santos VR, et al. (2017) Kappa opioid receptors regulate hippocampal synaptic homeostasis and epileptogenesis. Epilepsia
Huizenga MN, Wicker E, Beck VC, et al. (2017) Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in developing rats. Epilepsia
See more...